Form 8-K - Current report:
SEC Accession No. 0000912282-19-000059
Filing Date
2019-06-17
Accepted
2019-06-14 21:18:13
Documents
28
Period of Report
2019-06-14
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 rezolute8k_061419.htm 8-K 23551
2 CORPORATE PRESENTATION 3Q 2019 ex99_1.htm EX-99.1 10156
3 image00055.jpg GRAPHIC 119844
4 p1.jpg GRAPHIC 61821
5 p2.jpg GRAPHIC 78498
6 p3.jpg GRAPHIC 71187
7 p5.jpg GRAPHIC 36298
8 p6.jpg GRAPHIC 85460
9 p7.jpg GRAPHIC 80747
10 p8.jpg GRAPHIC 65056
11 p9.jpg GRAPHIC 61815
12 p10.jpg GRAPHIC 74487
13 p11.jpg GRAPHIC 72735
14 p12.jpg GRAPHIC 78812
15 p13.jpg GRAPHIC 81923
16 p14.jpg GRAPHIC 34476
17 p15.jpg GRAPHIC 91003
18 p16.jpg GRAPHIC 64203
19 p17.jpg GRAPHIC 80335
20 p18.jpg GRAPHIC 84641
21 p19.jpg GRAPHIC 73627
22 p20.jpg GRAPHIC 35071
23 p21.jpg GRAPHIC 76822
24 p22.jpg GRAPHIC 80260
25 p23.jpg GRAPHIC 72608
26 p24.jpg GRAPHIC 37753
27 p25.jpg GRAPHIC 58501
28 p26.jpg GRAPHIC 54870
  Complete submission text file 0000912282-19-000059.txt   2393265
Mailing Address 201 REDWOOD SHORES PARKWAY, SUITE 315 REDWOOD CITY CA 94065
Business Address 201 REDWOOD SHORES PARKWAY, SUITE 315 REDWOOD CITY CA 94065 650-847-1919
Rezolute, Inc. (Filer) CIK: 0001509261 (see all company filings)

EIN.: 273440894 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-54495 | Film No.: 19900252
SIC: 2834 Pharmaceutical Preparations